The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-06-26
DOI
10.1093/carcin/bgz123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
- (2019) Mohamed I Saad et al. EMBO Molecular Medicine
- ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
- (2018) Stefanie Schmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo
- (2018) Koichi Tomoshige et al. ONCOGENE
- Comprehensive bioinformatics analysis identifies several potential diagnostic markers and potential roles of cyclin family members in lung adenocarcinoma
- (2018) Li-Wei Gao et al. OncoTargets and Therapy
- Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema
- (2016) Saleela M. Ruwanpura et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis
- (2016) G. D. Brooks et al. CANCER RESEARCH
- Novel therapeutic targets on the horizon for lung cancer
- (2016) Wan-Ling Tan et al. LANCET ONCOLOGY
- Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
- (2016) Eitan Wong et al. Scientific Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Allergen-induced IL-6 trans-signaling activates γδ T cells to promote type 2 and type 17 airway inflammation
- (2015) Md Ashik Ullah et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
- (2015) Chee-Seng Tan et al. LANCET ONCOLOGY
- Blockade of IL-6TransSignaling Attenuates Pulmonary Fibrosis
- (2014) Thanh-Thuy T. Le et al. JOURNAL OF IMMUNOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis
- (2014) A Miller et al. ONCOGENE
- Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model
- (2014) A Baumgart et al. ONCOGENE
- Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation
- (2013) Yonka Christova et al. EMBO REPORTS
- Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
- (2013) L. Soucek et al. GENES & DEVELOPMENT
- Polo-like Kinase 2, a Novel ADAM17 Signaling Component, Regulates Tumor Necrosis Factor α Ectodomain Shedding
- (2013) Jeanette Schwarz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
- (2012) Christine M. Ardito et al. CANCER CELL
- The Cytosolic Domain of Protein-tyrosine Kinase 7 (PTK7), Generated from Sequential Cleavage by a Disintegrin and Metalloprotease 17 (ADAM17) and γ-Secretase, Enhances Cell Proliferation and Migration in Colon Cancer Cells
- (2012) Hye-Won Na et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
- (2012) Frances M. Richards et al. PLoS One
- TACE Activation by MAPK-Mediated Regulation of Cell Surface Dimerization and TIMP3 Association
- (2012) P. Xu et al. Science Signaling
- Reactive Oxygen Species and p38 Mitogen-activated Protein Kinase Mediate Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM-17) Activation in Primary Human Monocytes
- (2011) Alasdair J. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Different Signaling Pathways Stimulate a Disintegrin and Metalloprotease-17 (ADAM17) in Neutrophils during Apoptosis and Activation
- (2011) Yue Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway
- (2011) Ping Lin et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- TACE/ADAM-17 Phosphorylation by PKC-Epsilon Mediates Premalignant Changes in Tobacco Smoke-Exposed Lung Cells
- (2011) Hassan Lemjabbar-Alaoui et al. PLoS One
- ADAM17: a molecular switch to control inflammation and tissue regeneration
- (2011) Jürgen Scheller et al. TRENDS IN IMMUNOLOGY
- ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation
- (2010) Xuguang Zheng et al. CANCER BIOLOGY & THERAPY
- An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
- (2010) Qing Sheng et al. CANCER CELL
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Direct Activation of TACE-Mediated Ectodomain Shedding by p38 MAP Kinase Regulates EGF Receptor-Dependent Cell Proliferation
- (2010) Pinglong Xu et al. MOLECULAR CELL
- ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by γ-secretase
- (2009) Athena Chalaris et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started